Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Pathology

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2009.080792PMID 19834063PMCID PMC2774053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• How do mesangial and endothelial cells form the glomerular tuft?

  2008cited by this paper
• An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice

  2008cited by this paper
• Vascular endothelial growth factor and diabetic nephropathy

  2008cited by this paper
• Glomerular disease related to anti-VEGF therapy.

  2008cited by this paper
• VEGF inhibition and renal thrombotic microangiopathy.

  2008cited by this paper
• Volumetric high-frequency Doppler ultrasound enables the assessment of early antiangiogenic therapy effects on tumor xenografts in nude mice

  2008cited by this paper
• Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients

  2008cited by this paper
• Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat

  2008cited by this paper
• Vascular endothelial growth factor in eye disease.

  2008cited by this paper
• VEGF inhibition and renal thrombotic microangiopathy.

  2008cited by this paper
• A new look at platelet-derived growth factor in renal disease.

  2008cited by this paper
• VEGF receptor inhibition slows the progression of polycystic kidney disease.

  2007cited by this paper
• Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

  2007cited by this paper
• VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects.

  2007cited by this paper
• Ontogenetic Development of the Filtration Barrier

  2007cited by this paper
• Histopathology of diabetic nephropathy.

  2007cited by this paper
• Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

  2007cited by this paper
• Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

  2007cited by this paper
• Formation and function of the myofibroblast during tissue repair.

  2007cited by this paper
• Renal fibroblasts and myofibroblasts in chronic kidney disease.

  2006cited by this paper
• Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.

  2006cited by this paper
• Pathways to nephron loss starting from glomerular diseases-insights from animal models.

  2005cited by this paper
• The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease

  2005cited by this paper
• Vascular Endothelial Growth Factor Levels in Vitreous and Serum of Patients with either Proliferative Diabetic Retinopathy or Proliferative Vitreoretinopathy

  2005cited by this paper
• Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.

  2004cited by this paper
• Immunolocalization of ecto-5′-nucleotidase in the kidney by a monoclonal antibody

  2004cited by this paper
• The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

  2004cited by this paper
• Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice

  2004cited by this paper
• The role of VEGF-A in glomerular development and function

  2004cited by this paper
• Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung.

  2003cited by this paper
• Vascular Endothelial Growth Factor in Diabetic Nephropathy

  2003cited by this paper
• Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

  2003cited by this paper
• Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis.

  2003cited by this paper
• Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

  2003cited by this paper
• Technical Advance A New Method for Large Scale Isolation of Kidney Glomeruli from Mice

  2002cited by this paper
• Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver.

  2001cited by this paper
• Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

  2000cited by this paper
• Vascular Endothelial Growth Factor and Diabetic Nephropathy

  1999cited by this paper
• From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies.

  1998cited by this paper
• Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli.

  1998cited by this paper
• The interstitial response to renal injury: fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression.

  1997cited by this paper
• Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.

  1995cited by this paper
• Variability of intercellular spaces between macula densa cells: a transmission electron microscopic study in rabbits and rats.

  1982cited by this paper
• Stereological Methods. Practical methods for biological morphometry

  1979cited by this paper
• Kidney glomeruli.

  1974cited by this paper
• Embedding in epoxy resins for ultrathin sectioning in electron microscopy.

  1960cited by this paper

• Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease

  2025cites this paper
• The Role of the Vascular Niche in Regulating Kidney Tubulo-Interstitial Fibrosis.

  2025cites this paper
• Leucine-rich α-2-glycoprotein 1 can be a novel angiogenic mediator in autosomal dominant polycystic kidney disease

  2025cites this paper
• The KDR Gene rs2071559 and the VEGF Gene rs6921438 May Be Associated with Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus

  2024cites this paper
• Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO

  2024cites this paper
• Diabetic vascular diseases: molecular mechanisms and therapeutic strategies

  2023cites this paper
• Targeted deletion of von-Hippel-Lindau in the proximal tubule conditions the kidney against early diabetic kidney disease

  2023cites this paper
• Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney.

  2023cites this paper
• The Expression and Molecular Mechanisms of Matrix Metalloproteinase-9 and Vascular Endothelial Growth Factor in Renal Interstitial Fibrosis in Rats.

  2023cites this paper
• Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.

  2023cites this paper
• The vascular protective effect of matrix Gla protein during kidney injury

  2022influential citation
• Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome

  2022cites this paper
• Angiopoietin-2 inhibition attenuates kidney fibrosis by hindering chemokine C-C motif ligand 2 expression and apoptosis of endothelial cells.

  2022cites this paper
• Atypical Presentations

  2022cites this paper
• Kidney endothelial cell heterogeneity, angiocrine activity and paracrine regulatory mechanisms.

  2022cites this paper
• Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis.

  2022cites this paper
• Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria

  2021cites this paper
• Screening and Analysis of Key Genes in miRNA-mRNA Regulatory Network of Membranous Nephropathy

  2021cites this paper
• Histopathologic findings of TAFRO syndrome with immunohistochemical analysis of the kidney specimen: A case report

  2021cites this paper
• Defining therapeutic targets for renal fibrosis: Exploiting the biology of pathogenesis.

  2021cites this paper
• Endothelial-epithelial communication in polycystic kidney disease: Role of vascular endothelial growth factor signalling.

  2020cites this paper
• Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression

  2020influential citation
• Two cases of idiopathic multicentric Castleman disease with nephrotic syndrome treated with tocilizumab

  2020cites this paper
• Molecular pathways involved in injury-repair and ADPKD progression.

  2020cites this paper
• Role of oxygen and the HIF-pathway.

  2020cites this paper
• Targeting angiogenesis and lymphangiogenesis in kidney disease

  2020cites this paper
• Glomerular endothelial derived vesicles mediate podocyte dysfunction: A potential role for miRNA

  2020cites this paper
• Improvement of lenvatinib-induced nephrotic syndrome after adaptation to sorafenib in thyroid cancer: A case report

  2020cites this paper
• Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions

  2019cites this paper
• Curcumin Ameliorates Chronic Renal Failure in 5/6 Nephrectomized Rats by Regulation of the mTOR/HIF-1α/VEGF Signaling Pathway.

  2019cites this paper
• Differential roles of VEGF: Relevance to tissue fibrosis

  2019cites this paper
• Cellular and molecular mechanisms of kidney fibrosis.

  2019cites this paper
• Morphology and Evaluation of Renal Fibrosis.

  2019cites this paper
• Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review

  2019cites this paper
• Evolving spectrum of diabetic nephropathy

  2019cites this paper
• Renal Oxygenation and its Determinants in Chronic Kidney Disease

  2019cites this paper
• The 150-kDa oxygen-regulated protein (ORP150) regulates proteinuria in diabetic nephropathy via mediating VEGF.

  2019cites this paper
• Tipping the Balance from Angiogenesis to Fibrosis in Chronic Kidney Disease

  2018cites this paper
• Inverse correlation between vascular endothelial growth factor back-filtration and capillary filtration pressures

  2018cites this paper
• Renal hypoxia in kidney disease: Cause or consequence?

  2018cites this paper
• Maintenance and Breakdown of Glomerular Tuft Architecture.

  2018cites this paper
• Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression

  2018cites this paper
• Castleman disease mimicking systemic lupus erythematosus

  2018cites this paper
• Ethanol extract of gardenia fruit alleviates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats

  2017cites this paper
• EGF regulation of proximal tubule cell proliferation and VEGF‐A secretion

  2017cites this paper
• VEGF and the diabetic kidney: More than too much of a good thing.

  2017cites this paper
• Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice

  2017cites this paper
• Peritubular capillaries: an important piece of the puzzle.

  2017cites this paper
• Immunohistochemistry of Vasohibin-2 in Human Kidney Disease : Implications in Impaired Glucose Tolerance and Reduced Renal Function.

  2017influential citation
• Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease

  2017cites this paper
• From tubular sublimate nephropathy via urinary concentrating mechanism to glomerular disease—Wilhelm Kriz’s contribution to modern nephrology

  2017cites this paper
• Capillary rarefaction from the kidney point of view

  2017cites this paper
• Maladaptive Repair and AKI to CKD Transition

  2017cites this paper
• Le récepteur à domaine discoïdine de type 1 : un acteur majeur des pathologies rénales chroniques et aiguës

  2016cites this paper
• Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy

  2016cites this paper
• 7,8-DHF Treatment Induces Cyr61 Expression to Suppress Hypoxia Induced ER Stress in HK-2 Cells

  2016cites this paper
• DDR1 in Renal Function and Disease

  2016cites this paper
• Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis

  2016cites this paper
• Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.

  2016cites this paper
• Transactivation of EGFR by prostaglandin E2 receptors: a nuclear story?

  2015cites this paper
• Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney.

  2015cites this paper
• Diverse origins of the myofibroblast—implications for kidney fibrosis

  2015cites this paper
• Renal Allograft Fibrosis: Biology and Therapeutic Targets

  2015cites this paper
• Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

  2015cites this paper
• Hypoxia and Dysregulated Angiogenesis in Kidney Disease

  2015cites this paper
• Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells

  2015cites this paper
• Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53

  2015cites this paper
• Proteomic Characterization of Acyclovir-Induced Nephrotoxicity in a Mouse Model

  2014cites this paper
• The complexity of cell composition of the intima of large arteries: focus on pericyte-like cells.

  2014cites this paper
• The association between therapeutic outcomes and VEGF G-1154A and C-936T gene polymorphisms in patients with glomerulonephritis

  2014cites this paper
• Extensive podocyte loss triggers a rapid parietal epithelial cell response.

  2014cites this paper
• Severe renal mass reduction impairs recovery and promotes fibrosis after AKI.

  2014cites this paper
• Microparticles released by vascular endothelial cells increase hypoxia inducible factor expression in human proximal tubular HK-2 cells.

  2014cites this paper
• Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes

  2014cites this paper
• Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins

  2013cites this paper
• Action of hypoxia‐inducible factor in liver and kidney from mice with Pax8‐rtTA‐based deletion of von Hippel‐Lindau protein

  2013cites this paper
• All-trans retinoic acid protects renal tubular epithelial cells against hypoxia induced injury in vitro.

  2013cites this paper
• Renal albumin filtration: alternative models to the standard physical barriers

  2013cites this paper
• Angiogenesis and autosomal dominant polycystic kidney disease

  2013cites this paper
• Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease.

  2013cites this paper
• Angiogenesis and hypoxia in the kidney

  2013cites this paper
• Lipoprotein Modification: A Hallmark In The Progression Of Diabetic Nephropathy

  2012cites this paper
• Renal interstitial fibrosis: mechanisms and evaluation

  2012cites this paper
• Angiogenesis and the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease

  2012cites this paper
• Paracrine communications control reorganization of epithelial masses into polarized monolayers

  2012cites this paper
• Papel de la lipotoxicidad en el desarrollo de la lesión renal en el síndrome metabólico y el envejecimiento

  2012cites this paper
• Transforming Growth Factor b-1 Stimulates Pro fi brotic Epithelial Signaling to Activate Pericyte-Myo fi broblast Transition in Obstructive Kidney Fibrosis

  2012cites this paper
• Response of VEGF to activation of viral receptors and TNFα in human mesangial cells

  2012cites this paper
• Chemokine Cxcl9 attenuates liver fibrosis‐associated angiogenesis in mice

  2012cites this paper
• Novel Insights on Chronic Kidney Disease , Acute Kidney Injury and Polycystic Kidney Disease

  2012cites this paper
• Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.

  2012cites this paper
• VEGF and podocytes in diabetic nephropathy.

  2012cites this paper
• Frontiers in Research Review: Chronic Kidney Disease Chronic kidney disease growth factors in renal fibrosis

  2011cites this paper
• Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

  2011cites this paper
• Selective stimulation of VEGFR2 accelerates progressive renal disease.

  2011cites this paper
• Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release - just theory or a causal relationship?

  2011cites this paper
• Chronic kidney disease growth factors in renal fibrosis

  2011cites this paper
• Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.

  2011cites this paper
• The influence of vascular endothelial growth factor (VEGF) polymorphism on the progression of chronic glomerulonephritides.

  2011cites this paper
• Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis.

  2011cites this paper